Sign in
4

Changes in Ownership

Indaptus Therapeutics, Inc. Filed Acc 0001493152-21-018909

Options or other derivatives

  • Director acquired 41,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Pomerantz Roger Director 2021-08-04 Grant or award · Stock Option (right to buy) +41,000 41,000 D
Loading xslF345X03/ownership.xml…